Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab
Patent No. EP4403228 (titled "Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab") was filed by F Hoffmann LA Roche on Oct 11, 2012. The application was issued on Jul 16, 2025.
Patent Summary
Patent Family
Patent Oppositions (2)
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP4403228
- Application Number
- EP24174637A
- Filing Date
- Oct 11, 2012
- Status
- Granted And Under Opposition
- Jun 13, 2025
- Publication Date
- Jul 16, 2025
- External Links
- Slate, Register , Google Patents